• HCM and New Pharmacological Agents

  • Jun 27 2022
  • Length: 37 mins
  • Podcast

HCM and New Pharmacological Agents

  • Summary

  • Making the correct of hypertrophic cardiomyopathy (HCM) is critical in being able to initiate early surveillance and therapy to improve patient outcomes.  In this podcast focusing on pharmacologic treatment options, learn more about completed and ongoing myosin inhibitor clinical trials.

    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about HCM and New Pharmacological Agents

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.